Cartesian Therapeutics, Inc. (RNAC)
6.86
+1.00
(+17.06%)
USD |
NASDAQ |
Jun 09, 14:52
Cartesian Therapeutics Shareholders Equity (Quarterly) : -148.12M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| C4 Therapeutics, Inc. | 234.25M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Oncolytics Biotech, Inc. | -5.13M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.505B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 288.39M |
| Total Liabilities (Quarterly) | 436.51M |
| Debt to Equity Ratio | -0.08 |
| Current Ratio | 7.654 |
| Net Debt Paydown Yield | 0.32% |